Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion

Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

Frequently Asked Questions

What is "Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion" about?

Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.

When was "Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion" published?

It was published on October 2, 2026 on Semasocial.

Who wrote "Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion"?

It was written by CNBC on Semasocial.

Comment